È cambiata la prognosi della fibrosi cistica? - Primula Multimedia

95. de Lange EE, Mugler JP 3rd, Brookeman JR, et
al. Lung air spaces: MR imaging evaluation with hyperpolarized
3He gas. Radiology 1999; 210: 851-857.
96. Donnelly LF, MacFall JR, McAdams HP, et al.
Cystic fibrosis: combined hyperpolarized 3Heenhanced
and conventional proton MR imaging in
the lung - preliminary observations. Radiology
1999; 212: 885-889.
97. Moller HE, Chen XJ, Saam B, et al. MRI of the
lungs using hyperpolarized noble gases. Magn
Reson Med 2002; 47: 1029-1051.
98. Altes TA, de Lange EE. Applications of hyperpolarized
helium-3 gas magnetic resonance imaging
in pediatric lung disease. Top Magn Reson Imaging
2003; 14: 231-236.
99. van Beek EJ, Wild JM, Kauczor HU, et al.
Functional MRI of the lung using hyperpolarized 3-helium
gas. J Magn Reson Imaging 2004; 20: 540-554.
100. Kauczor HU, Hofmann D, Kreitner KF, et al.
Normal and abnormal pulmonary ventilation: visualization
at hyperpolarized He-3 MR imaging.
Radiology 1996; 201: 564-568.
101. McAdams HP, Palmer SM, Donnelly LF, et al.
Hyperpolarized 3He-enhanced MR imaging of lung
transplant recipients: preliminary results. AJR Am J
Roentgenol 1999; 173: 955-959.
102. Guenther D, Eberle B, Hast J, et al. (3)He
MRI in healthy volunteers: preliminary correlation
with smoking history and lung volumes. NMR
Biomed 2000; 13: 182-189.
103. Altes TA, Powers PL, Knight-Scott J, et al.
Hyperpolarized 3He MR lung ventilation imaging in
asthmatics: preliminary findings. J Magn Reson
Imaging 2001; 13: 378-384.
104. Salerno M, Altes TA, Mugler JP 3rd, et al.
Hyperpolarized noble gas MR imaging of the lung:
potential clinical applications. Eur J Radiol 2001;
40: 33-44.
105. Jolliet P,Tassaux D. Helium-oxygen ventilation.
Respir Care Clin N Am 2002; 8: 295-307.
106. de Lange E, Altes T, Harding D, et al.
Hyperpolarized gas MR imaging of the lung: safety
assessment if inhaled helium-3. In: Radiological
Society of North America. Chicago, IL, 2003.
107. Koumellis P, van Beek EJ,Woodhouse N, et al.
Quantitative analysis of regional airways obstruction
La diagnostica per immagini polmonari: cosa c’è di nuovo?
using dynamic hyperpolarized 3He MRI-preliminary
results in children with cystic fibrosis. J Magn Reson
Imaging 2005; 22: 420-426.
108. Mentore K, Froh D, de Lange EE, et al.
Hyperpolarized helium-3 MR imaging of the lung in
cystic fibrosis: assessment at baseline and changes
following bronchodilator and airway clearance treatment.
Academic Radiology in stampa.
109. Papanicolaou N, Treves S. Pulmonary scintigraphy
in pediatrics. Semin Nucl Med 1980; 10: 259-285.
110. Goudard E, Fauveau-Robine G, Grimfeld A.
Interest of lung scintigraphy for the follow-up of cystic
fibrosis (CF) and other chronic obstructive pulmonary
disease (COPD). Two case reports in children.
Arch Pediatr 2005; 12; 1487-1491.
111. Coates AL, Boyce P, Shaw DG, et al.
Relationship between the chest radiograph, regional
lung function studies, exercise tolerance, and clinical
condition in cystic fibrosis. Arch Dis Child 1981; 56:
106-111.
112. Ericsson A, Strandvik B,Troell S, Freyschuss
U. Relation between clinical and roentgenological
scores and measures of lung function in cystic fibrosis,
with special reference to pulmonary Xenon133
elimination. Clin Physiol 1987; 7: 275-282.
113. Brown JS, Zeman KL, Bennett WD. Regional
deposition of coarse particles and ventilation distribution
in healthy subjects and patients with cystic
fibrosis. J Aerosol Med 2001; 14: 443-454.
114. Kastelik JA, Wright GA, Aziz I, et al. A widely
available method for the assessment of aerosol
delivery in cystic fibrosis. Pulm Pharmacol Ther
2002; 15: 513-519.
115. Itti E, Fauroux B, Pigeot J, et al. Quantitative
lung perfusion scan as a predictor of aerosol distribution
heterogeneity and disease severity in children
with cystic fibrosis. Nucl Med Commun 2004; 25:
563-569.
116. Santamaria F, Celentano L, Buonpensiero P, et
al. Positive expiratory pressure treatment: efficacy in
pulmonary diseases. J Pediatr 1998; 133: 717-718.
117. Stanchina ML, Tantisira KG, Aquino SL, et al.
Association of lung perfusion disparity and mortality in
patients with cystic fibrosis awaiting lung transplantation.
J Heart Lung Transplant 2002; 21: 217-225.
BIBLIOGRAFIA
37